Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.

Angiogenesis in cancer, vascular, rheumatoid and other disease

1995 • 7,717 citations

LNCaP model of human prostatic carcinoma.

1983 • 1,749 citations

Activation of Programmed Cell Death in the Rat Ventral Prostate after Castration*

1988 • 730 citations

Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.

1990 • 485 citations

Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers

1986 • 412 citations

Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study

1992 • 237 citations

Polymerization of deoxyribonucleotides in relation to androgen-induced prostatic growth

1968 • 208 citations

Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.

1995 • 192 citations

Antiangiogenic effects of the quinoline-3-carboxamide linomide.

1993 • 104 citations

Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.

1997 • 102 citations

Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.

1995 • 99 citations

Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix

1992 • 96 citations

Vascular Permeability Factor (Vascular Endothelial Growth Factor) is Strongly Expressed in the Normal Male Genital Tract and is Present in Substantial Quantities in Semen

1995 • 81 citations

Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction.

1995 • 68 citations

Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.

1996 • 57 citations

The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.

1992 • 56 citations

Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.

1995 • 56 citations

Tumour angiogenesis in latent prostatic carcinoma

1994 • 54 citations

Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.

1982 • 36 citations

Anti-Angiogenic Treatment with Linomide as Adjuvant to Surgical Castration in Experimental Prostate Cancer

1997 • 27 citations

The antiangiogenic agent linomide inhibits tumor necrosis factor-α secretion via inhibition of its synthesis

1996 • 16 citations